Home > Riviste > Giornale Italiano di Dermatologia e Venereologia > Fascicoli precedenti > Giornale Italiano di Dermatologia e Venereologia 2017 December;152(6) > Giornale Italiano di Dermatologia e Venereologia 2017 December;152(6):642-50



Publication history
Per citare questo articolo


Rivista di Dermatologia e Malattie Sessualmente Trasmesse

Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311




Giornale Italiano di Dermatologia e Venereologia 2017 December;152(6):642-50

DOI: 10.23736/S0392-0488.17.05683-8


lingua: Inglese

Management of mycoses in daily practice

Lorenzo DRAGO 1, 2, Giuseppe MICALI 3, Manuela PAPINI 4, Bianca M. PIRACCINI 5, Stefano VERALDI 6

1 Laboratory of Clinical Analyses, IRCCS Galeazzi Hospital, Università degli Studi di Milano, Milan, Italy; 2 Laboratory of Technical Sciences for Laboratory Medicine, Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy; 3 Section of Dermatology, Department of Medical and Surgical Specialties, University of Catania, Catania, Italy; 4 Department of Surgical and Biomedical Sciences, Università degli Studi di Perugia, Perugia, Italy; 5 Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, Università degli Studi di Bologna, Bologna, Italy; 6 Department of Pathophysiology and Transplantation, Università degli Studi di Milano, IRCCS Foundation, Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy


The guideline recommendations, albeit founded on thorough reviews of clinically relevant literature data, are often not immediately adaptable to everyday life. Considering the marked heterogeneity of superficial mycoses, each of them requires specific management in a real life context; in all cases diagnostic confirmation is required with microscopic and culture examination. In tinea capitis oral therapy is necessary (minimum six weeks) and should be continued until clinical and, above all, mycological healing. In cases of tinea corporis, cruris or pedis, it may be necessary to associate oral therapy to topical treatment. The main oral antifungals are fluconazole, itraconazole and terbinafine. Fluconazole has favorable pharmacokinetic and pharmacodynamic characteristics, and is effective in most superficial mycoses, for example in cases of diffuse or recurrent pityriasis versicolor in which oral therapy with an azole derivative is useful. Topical treatment, lasting 6-12 months, is indicated in onychomycosis that is confined to one nail. In frequent cases of onychomycosis involving multiple nails or recurrence, oral therapy is necessary. Pharmacological history is important, given the possible interactions of some systemic drugs. In chronic or recurrent relapsing vulvovaginitis, first-choice therapy is oral fluconazole with a therapeutic regimen that respects the mycotic biorhythm (200 mg on days 1, 4, 11, 26, and subsequently 200 mg/week for 3 months).

KEY WORDS: Mycoses - Disease management - Dermatology

inizio pagina

Publication History

Issue published online: October 18, 2017
Manuscript accepted: May 10, 2017
Manuscript received: May 10, 2017

Per citare questo articolo

Drago L, Micali G, Papini M, Piraccini BM, Veraldi S. Management of mycoses in daily practice. G Ital Dermatol Venereol 2017;152:642-50. DOI: 10.23736/S0392-0488.17.05683-8

Corresponding author e-mail